<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01310608</url>
  </required_header>
  <id_info>
    <org_study_id>A-View 3</org_study_id>
    <nct_id>NCT01310608</nct_id>
  </id_info>
  <brief_title>Effect Study of Modified Transoesophageal Echocardiography on Cerebral Embolization After Cardiothoracic Surgery</brief_title>
  <official_title>Effect of Preoperative Imaging of the Ascending Aorta With Modified Transoesophageal Echocardiography on New Dw-MRI Lesions After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isala</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zorgvernieuwing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Isala</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing cardiac surgery frequently develop neurologic complications, ranging from
      subtle cognitive changes to evident confusion, delirium, and stroke. This continuum of
      complications is commonly caused by embolization in the brain due to manipulation of
      atherosclerotic parts of the aorta ascendens (AA) during surgery. Timely detection of AA
      atherosclerosis before surgery enables the surgeon to consider changes of the surgical plan,
      to reduce the risk of embolization and thus subsequent neurologic complications.

      Various methods exist to visualize the AA to detect atherosclerosis. Epiaortic ultrasound
      scanning has become the gold standard, but is seldom used as it interferes often with
      surgical plan and can only be used after sternotomy. Transesophageal echocardiography (TEE)
      is a widely used imaging method permitting evaluation of the aorta preoperatively, but
      assessment of distal AA is hampered by interposition of air-filled trachea between esophagus
      and AA. The A-View速 (Aortic-view) method, a modification of conventional TEE using a
      fluidfilled balloon, overcomes this limitation. The safety and diagnostic accuracy of the
      A-View速 have successfully been shown in previous studies. The hypothesis of this study is
      that the use of A-View will reduce cerebral embolization secondary to a change of surgical
      technique.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New diffusion-weighted lesions on cerebral MRI</measure>
    <time_frame>3 - 4 Days after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The number, size, and location of new ischemic lesions on the postoperative DW-MRI</measure>
    <time_frame>3 - 4 Days after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any neurologic event during the first six postoperative weeks, which is manifested as either stroke, or transient ischemic attack (TIA), epileptic insults, or delirium, or cognitive deficit</measure>
    <time_frame>6 weeks postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke or TIA during the first three postoperative months</measure>
    <time_frame>3 months postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium during hospital stay</measure>
    <time_frame>Until hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 weeks and 1 year after the intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of &quot;HITS&quot; detected by Transcranial Doppler</measure>
    <time_frame>peroperive</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Near Infrared Spectrography desaturations (NIRO 2000)</measure>
    <time_frame>Peroperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short psychometric test</measure>
    <time_frame>6 weeks after intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Coronary Artery Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>A-View</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No A-View</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>A-View</intervention_name>
    <description>Pre-operative imaging of the thoracic aorta with A-View technique</description>
    <arm_group_label>A-View</arm_group_label>
    <other_name>The A-View速</other_name>
    <other_name>Aortic-view速</other_name>
    <other_name>Modified transoesophageal echocardiography</other_name>
    <other_name>FDA: 070515</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Isolated CABG

          -  Elective surgery

          -  Stroke Risk Index &lt;75(Newman, '96)

        Exclusion Criteria:

          -  Other than isolated CABG

          -  Contra-indication for TEE

          -  Contra-indication for A-View

          -  Contra-indication for MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arno Nierich, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Isala</affiliation>
  </overall_official>
  <removed_countries>
    <country>Netherlands</country>
  </removed_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2011</study_first_submitted>
  <study_first_submitted_qc>March 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2011</study_first_posted>
  <last_update_submitted>August 7, 2012</last_update_submitted>
  <last_update_submitted_qc>August 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isala</investigator_affiliation>
    <investigator_full_name>Arno P. Nierich</investigator_full_name>
    <investigator_title>MD. PhD</investigator_title>
  </responsible_party>
  <keyword>Atherosclerosis aorta</keyword>
  <keyword>A-View</keyword>
  <keyword>Distal ascending aorta</keyword>
  <keyword>Transoesophageal echocardiography</keyword>
  <keyword>CABG</keyword>
  <keyword>Cerebral embolisation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

